StreetAlpha.app
Home › Stocks › CVSA

Covista Inc. (CVSA)

Consumer Defensive
$109.13
▼ −5.52%
LAST CLOSE · NOV 20

Covista runs universities that offer degree and certificate programs in nursing, healthcare, medicine, and veterinary medicine. It last closed at $109.13 on Nov 20, down 5.52% on the day. The next earnings report for CVSA is expected around Wed, Jan 27, 2027, after the close. For the quarter ended Sep 2026, CVSA reported EPS of $1.95 on revenue of $511.5M, with revenue up 10.7% from a year ago. Over its last 8 reports the stock moved an average of 11.7% the session after earnings. Over the last 12 months CVSA insiders bought $3.8M of stock on the open market and sold $10.3M, according to SEC Form 4 filings.

AI Auto Pilots
Is CVSA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CVSA.

Key Stats

Last 12 months
Results
Revenue
$2.0B
+9.3% vs a year ago
Net income
$257.2M
+1.8% vs a year ago
EPS (diluted)
$7.32
+9.7% vs a year ago
Free cash flow
$354.6M
17.7% margin
Valuation
Market cap
$3.6B
33.3M shares
P/E
14.9
Price over 12 month EPS
Price to sales
1.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$222.2M
At Sep 30
Debt
$500.2M
At Sep 30
Shareholder equity
$1.4B
Buybacks
$313.3M
Last 12 months
Fiscal year endsJune
ExchangeNYSE
Financials history
FY2022: $1.4B$1.4BFY2022FY2023: $1.5B$1.5BFY2023FY2024: $1.6B$1.6BFY2024FY2025: $1.8B$1.8BFY2025FY2026: $2.0B$2.0BFY2026

From CVSA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Jan 27
Estimated date · After the close
Reported EPS
$1.95
Quarter ended Sep 2026
Year ago EPS
$1.67
+16.8% on a GAAP basis
Revenue
$511.5M
+10.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $1.98Dec '24Mar 2025: $1.59Mar '25Jun 2025: $1.44Jun '25Sep 2025: $1.67Sep '25Dec 2025: $2.11Dec '25Mar 2026: $1.20Mar '26Jun 2026: $2.05Jun '26Sep 2026: $1.95Sep '26Latest $1.95
Revenue by quarter
Dec 2024: $447.7MDec '24Mar 2025: $466.1MMar '25Jun 2025: $457.1MJun '25Sep 2025: $462.3MSep '25Dec 2025: $503.4MDec '25Mar 2026: $487.0MMar '26Jun 2026: $501.4MJun '26Sep 2026: $511.5MSep '26Latest $511.5M
How CVSA moved after its last 8 reports
Average move the session after a report ±11.7%
Oct 29, 2026After the close−3.4%
Aug 6, 2026After the close+13.5%
May 7, 2026After the close+14.3%
Jan 28, 2026After the close−7.0%
Oct 30, 2025After the close−30.9%
Aug 7, 2025After the close+2.2%
May 8, 2025After the close+17.6%
Jan 30, 2025After the close+4.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CVSAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CVSA
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CVSA

Technical Analysis

CVSA · as of the Nov 20 close · updated each morning
Turning down, nearing oversold

The stock is 10% below its 20 day and 13% below its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the swing low (Nov 6) at $107.45, and the nearest resistance the Pivot at $112.07.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 4.7%/day
Key levels
$142.1352 week high+30.2%
$125.87100 day average+15.3%
$123.7150 day average+13.4%
$122.03Swing high (Nov 12)+11.8%
$120.0420 day average+10.0%
$120.04200 day average+10.0%
$115.12Pivot R1+5.5%
$112.07Pivot+2.7%
$109.13Last close
$107.45Swing low (Nov 6)−1.5%
$106.08Pivot S1−2.8%
$86.9752 week low−20.3%
Indicators
RSI (14)33.13Weak, oversold below 30Neutral
MACD-3.11Below its signal lineBearish
Stochastic32.8Middle of its rangeNeutral
ADX (14)26.9Trending down
Williams %R-90.9Oversold below −80, overbought above −20Oversold
CCI (20)-112.4Oversold below −100, overbought above 100Oversold
Rate of change−1.1%Change over 10 sessionsBearish
ATR (14)$5.18Typical daily range, 4.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CVSA

What happened before

See how CVSA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CVSA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CVSA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CVSAHow many large options trades hit CVSA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

CVSA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●186 buying vs 186 selling
  • ▲Held by funds +0.5 pts
  • ▲Funds holding +9
  • ▼Superinvestors: 1 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding388379+2.4%
In funds' top 1013−66.7%
Held by funds103.8%103.3%+0.5 pts
New / increased54 / 13251 / 144−4.6%
Reduced / sold out142 / 44133 / 31+13.4%
Put/call ratio1.20––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CVSA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CVSA Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$3.8M2 buys · 1 insider
Sold$10.3M13 sales · 5 insiders
100% of the selling was under pre-arranged trading plans.
2026-03 bought $3.8M2026-05 sold $4.8M2026-06 sold $690K2026-07 sold $2.1M2026-08 sold $1.6M2026-10 sold $1.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Oct 9Stephen W. BeardChairman & CEOSale plan8,306$130.59$1.1M
Aug 27Manjunath GangadharanVP, Chief Accounting OfficerSale plan1,802$137.18$247K
Aug 11Stephen W. BeardChairman & CEOSale plan3,545$130.34$462K
Aug 7Douglas G. BeckSVP, GC, Corp. Sec & ISSSale plan4,526$135.81$615K
Aug 7Robert J. PhelanCFOSale plan2,186$135.15$295K
Jul 13Stephen W. BeardChairman & CEOSale plan5,291$132.75$702K
Every insider buy and sale for CVSA over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CVSA insider trades →

From SEC Form 4 filings by CVSA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CVSA is in one of them and how their past CVSA trades turned out.

CVSA in the AI portfolios
Loading…

CVSA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CVSA in an article yet. Here's the latest on the wider market.

CVSA in the news

About Covista

Covista is an education company based in Chicago that runs universities offering degree and certificate programs. Its schools focus on nursing and other health professions, along with medicine and veterinary medicine. Its Walden unit serves working adults, mostly through online programs in fields such as education, psychology, social work, and business. Its students are mainly people preparing for careers in healthcare and related fields.

Headquarters
Chicago, IL